Connect with us

POZ

Roadmap for speedy development of HIV vaccine announced

As scientific discoveries lead to promising new approaches to HIV vaccine development, and with several large-scale vaccine efficacy studies underway, a new strategy takes a fresh look at the major challenges confronting the HIV vaccine paradigm.

Published

on

Photo by Sara Bakhshi from Unsplash.com

The Global HIV Vaccine Enterprise, hosted by the International AIDS Society (IAS), launched a five-year strategy to accelerate the development of an effective vaccine to prevent HIV infection. The new Global HIV Vaccine Enterprise Strategic Plan (2018-2023) was unveiled at the opening of HIV Research for Prevention (HIVR4P 2018), the world’s only scientific conference dedicated exclusively to biomedical HIV prevention, in Madrid, Spain.

“This strategy presents an opportunity to address some of the most significant challenges in HIV vaccine development today,” IAS President Anton Pozniak said.

The new strategy evaluates current opportunities, challenges and obstacles in HIV vaccine research and development and recommends a series of steps to:

  • Propel the vaccine pipeline by strengthening strategies to align, amplify and accelerate development of candidate vaccines
  • Prepare for success by tackling priorities essential to clarifying the roadmap for future access to a vaccine
  • Expand resources and engagement by enlisting a diverse community of partners to support and contribute to the field.

The new strategic plan was developed through an IAS-led consultation involving HIV vaccine research and funding stakeholders, the Enterprise Strategic Advisory Group and the IAS Governing Council. The plan advances the ongoing partnership between the IAS, the world’s largest association of HIV professionals, and the Global HIV Vaccine Enterprise, which promotes coordination, collaboration and resource mobilization to accelerate HIV vaccine development.

“While the HIV vaccine landscape offers greater scientific promise than ever before, the field also faces real challenges in terms of aligning scientific priorities, developing the smartest and most effective research studies, maintaining funding and engaging and maximizing the contributions of all global stakeholders in the search for a vaccine,” Pozniak added.

READ:  Red Fox: ‘Don’t give up, everything will be fine’

“The new strategy builds on more than a decade of work by the Global HIV Vaccine Enterprise to identify critical gaps in systems and knowledge, promote collaboration and address one of the greatest scientific challenges of our time.”

As scientific discoveries lead to promising new approaches to HIV vaccine development, and with several large-scale vaccine efficacy studies underway, the new strategy takes a fresh look at the major challenges confronting the HIV vaccine paradigm. Among these are:

  • The increasing complexity of conducting vaccine efficacy trials as more biomedical HIV prevention options become available
  • The need to address critical gaps in scientific knowledge about immune responses to HIV
  • Stagnant funding and the need to increase government and industry commitment and investment to meet emerging vaccine research opportunities
  • Uncertainty about regulatory and access pathways for a successful vaccine.

To address these challenges and others, the IAS/Enterprise plan proposes a series of near-term activities to address critical, of-the-moment challenges, along with longer-term goals and guideposts to measure achievements and guide adjustments in the strategy as the field evolves. The plan’s activities will be sequenced strategically and guided by annual implementation plans – with detailed activities, timelines and deliverables.

“This plan captures the promise and challenges of a unique and exciting moment in HIV vaccine development and offers a roadmap for action to bring us closer to the end of this epidemic,” President of the South African Research Council Glenda Grey said.

“With the support, expertise and convening power of IAS, this new strategic plan will build on the Enterprise’s longstanding role as a both a neutral convener and facilitator of collaboration in the HIV vaccine field and propel realizing our shared vision to develop a safe, effective and globally available HIV vaccine.”

READ:  New Mindanao HIV/AIDS treatment hub named

NEWSMAKERS

Cebu’s Deaf community taught community-based HIV screening

Select members of the Deaf community from the Province of Cebu were trained on the basics of HIV, and on community-based HIV screening in an effort to “inform them that this issue is just as important to them, and that – given the chance – they can help become the solutions to deal with this.”

Published

on

Helping Deaf Filipinos to help themselves.

Select members of the Deaf community from the Province of Cebu were trained on the basics of HIV, and on community-based HIV screening in an effort to “inform them that this issue is just as important to them, and that – given the chance – they can help become the solutions to deal with this,” said Disney Aguila of Bahaghari Center for Research, Education an Advocacy, Inc. (Bahaghari Center) and Pinoy Deaf Rainbow, Inc.

The training is part of a project by Bahaghari Center, backed by collaboration between Youth LEAD and Y-PEER (Asia Pacific Center), which eyes to address Sexual Reproductive Health and Rights (SRHR)needs of Young Key Populations (YKPs) In Asia and the Pacific.

This project is also a follow-through of the public service announcements (PSAs) developed in Filipino Sign Language (FSL) to specifically tap the Deaf community.

PSA on HIV basics released in Filipino Sign Language

PSA on getting tested for HIV released in Filipino Sign Language

PSA deals in Filipino Sign Language what happens after rapid HIV test

Aguila lamented that “perhaps because the Deaf community is often left behind in HIV-related efforts, we have a lot of catching up to do,” she said.

In Cebu City, for instance, even if participants recognized the importance/urgency of tackling HIV, there are sectors that are still “unable to go beyond their fear of talking about sex and sexuality.”

Noticeably, the Hearing community “may already talk about SOGIE concepts and so on, but – because we have not always been included in discussions, we’re still learning the basics,” Aguila said.

READ:  A chat with an orgiast

This is why, for Aguila, every effort counts to “ensure that we are included in the discussions; and perhaps just as importantly, also empowered so that we need not be dependent on the Hearing community just to be able to access lifesaving services.”

Aguila said that “this development may not come immediately, but every step leading there helps.”

The community-based HIV screening trainings are provided by The Red Ribbon Project, Inc.

Other supporters of the project include: Outrage Magazine, Fringe Publishing, Pinoy Deaf Rainbow, TransDeaf Philippines, Deaf Dykes United and Pinoy Deaf Queer.

Continue Reading

Editor's Picks

Worsening #ARVshortage in the Phl?

On Jan. 9, the Philippines gained a new HIV and AIDS law that is supposed to better the lives of Filipinos living with HIV. But many in the HIV community mark this day with distress, largely because of the worsening ARV shortage.

Published

on

In September 2018, Xander (not his real name; anonymity requested), a Filipino living with HIV, claimed that he was told by the person working in the pharmacy of his hub to “consume already-expired medicines (the three-in-one tablet of Lamivudine/Tenofovir/Efavirenz)”, and that “it is “still good for three months after the expiration date.”

Since dealing with ARV-related issue is not new to him (it happened to him in the last quarter of 2013), he complained and was given newer meds. Noticeably, “those who didn’t complain – like I did – ended up using the expired meds,” he said.

Xander can only recall how he earlier lamented – again in 2013 – that the ARV shortage will happen again, particularly considering the continuing denial of the Department of Health (DOH) about this issue.

TAINTED ‘SUCCESS’

The 9th of January is supposed to be a happy day particularly for Filipinos living with HIV and their advocates. On that day, the newly-signed Republic Act 11166 or the Philippine HIV and AIDS Policy Act was released after it was signed into law by Pres. Rodrigo Roa Duterte. By replacing the 20-year-old Republic Act 8504 or the Philippine National AIDS and Control Act of 1998, this new law is supposed to boost the government’s response to HIV and AIDS by making health services for HIV and AIDS more accessible to Filipinos.

But many in the HIV community mark this day with distress, largely because of the worsening ARV shortage, which is not helped by the denial of the issue by various heads of offices – including government officials, as well as those helming treatment hubs/facilities and even select non-government organizations (NGOs).

In an unsigned statement (as if so that no one can be “chased” to be held accountable for the same statement), the DOH seemed to belittle the issue by outright claiming that there’s an ‘alleged’ shortage of ARVs; even as it also stated that they take the issue of HIV infection in the country seriously. Part of this is to take “great steps to ensure that access for HIV treatments are available for those who are diagnosed with HIV.”

The DOH statement added:
“As of October 2018, we have enrolled 32,224 persons living with HIV for treatment with ARV such as Nevirapine, Lamivudine/Tenofovir. The DOH has been providing free ARV to Filipinos living with HIV through our HIV treatment hubs.
“Based on our records, there are 3,200 registered PLHIV who are on Nevirapine and 1,791 PLHIV on Lamivudine/Tenofovir, as of December last year.

READ:  New Mindanao HIV/AIDS treatment hub named

That just about half of the total PLHIVs in the Philippines use ARVs is worth noting, even if it’s another issue altogether.

But the mention of these two meds/cocktails is important because the complaints reaching – among others – Outrage Magazine, Bahaghari Center for SOGIE Research, Education and Advocacy, Inc. (Bahaghari Center) other and HIV-related community-based organizations/non-government organizations particularly currently mention these.

In Quezon City, for instance, at least eight PLHIVs alleged that they have been given incomplete medications – i.e. they were supplied with either Lamivudine/Tenofovir or Lamivudine/Zidovudine, but they have not been receiving Nevirapine because this is not available. These people are, therefore, taking incomplete meds.

Pinoy Plus’s hotline, PRC, has received similar allegations of non-delivery of Nevirapine.

In Cavite (Imus, Bacoor and Dasmariñas), at least three clients surfaced to allege about the same issue. PLHIVs are now “borrowing” each others’ Nevirapine supply just so they don’t miss their required dosage because their hub does not have supplies from the DOH.

There are similar allegations in Cagayan de Oro City, Davao City and Zamboanga City.

And in Alabang, the pharmacy of a treatment hub even posted on January 8, 2019 an announcement that “due to the shortage and delay of the deliveries at DOH, only one bottle will be dispensed of the following medicines: Nevirapine (200mg tablet); Lamivudine (150mg)/Zidovudine (300mg tablet); and Lamivudine (300mg)/Tenofovir (300mg tablet).” The same hub is telling its clients to “wait for further announcement on stock availability.”

Note that the RITM-AIDS Research Group’s pharmacy is putting the blame on the DOH.

DOH’s CLAIM

The same DOH statement stressed that “the latest data, as of January 4, confirms that Nevirapine has already been delivered to the 16 treatment hubs to meet the requirements for February-April 2019. For Lamivudine/Tenofovir, a month’s supply has also been delivered to Regions X, VI and I. The rest of the regions will expect deliveries within this week.”

READ:  Germaine Trittle PeBenito Leonin: Highlighting Vigilance

Noticeably, the DOH statement responds to issues only this January, even if this concern has been circulating in the PLHIV community since 2018, and only peaked now.

There are fewer ARV refills now. If, in the past, the usual practice is for hubs to give PLHIVs three bottles of ARV to last them for three months, a growing number are now complaining about the supply being cut to one month in numerous hubs – e.g. there’s that post in RITM’s pharmacy. Some allege that they are even supplied ARVs just for a week or even just for three days.

Due to the ARV shortage that the DOH is not outright confronting, expired medicines are allegedly being given to PLHIVs – as in the case of Xander.

Also due to the ARV shortage, the medication of a number of PLHIVs are allegedly being changed not because it’s medically sound, but because their usual medicines are not readily available. In Mandaluyong City, there are PLHIVs who claimed to have been told to use Lamivudine/Tenofovir/Efavirenz because it’s the only available ARV. If they refuse to do so, then they will have to stop taking their usual medications until such time when the delivery of supplies are normalized again.

To allow the DOH to respond to these claims, Outrage Magazine repeatedly reached out to the government body. Upon calling the media relations unit (at +63 2 651-7800 loc. 1126), we were turned over to the office of Dr. Gerard Belimac (+63 2 651-7800 locs. 2355, 2352, 2354). Five attempts were made to speak with Belimac or any other authority in his office, but he has been unavailable at those five times; and even after leaving requests for a statement from him on the ARV shortage, as of press time, the publication has not heard back.

As this is a continuing story, coordination will continue to – eventually hopefully – extensively hear from the DOH on this issue.

WHAT NOW?

The DOH statement also stated that it is “working closely with our suppliers to ensure that there are no gaps in our supply chain. In fact, we are waiting for deliveries of an additional 12,375 bottles of Nevirapine good for another three months and 7,024 bottles of Lamivudine/Tenofovir good for another two months.”

READ:  Why are religious, anti-LGBTQ conservatives obsessed with sex organs?

The DOH also claimed that it is continuing to explore “for more partners in providing excellent support for Filipinos living with HIV-AIDS and in ending the deadly disease.”

As if wanting to pacify the complaining PLHIVs, the DOH statement transferred to responsibility to “HIV doctors to explore possible options”, or visit Facebook page (PLHIV Response Center) or email dohnaspcphiv@gmail.com. Note the use of a gmail account for a body with millions in budget.

No investigations on where the errors in the supply chain is happening so that these can be fixed is forthcoming. No one being held accountable here.

THE NEED TO GO BEYOND LIP SERVICE

Incidentally, Article V, Sec. 33 of the newly signed HIV law states: “The DOH shall establish a program that will provide free and accessible ART and medication for opportunistic infections to all PLHIVs who are enrolled in the program… A manual of procedures for management of PLHIV shall be developed by the DOH.”

The IRR is not even there yet, but this mandate to provide life-saving meds is now already cast in doubt.

Xander – who only had a refill of his ARVs – said that many like him who posted about this issue online were told to stop doing so “because we are supposedly creating panic among PLHIVs.”

He now says that people who cover up this issue are “as worse as those paid to work on this issue. Because if you go to the HIV community, we’ve long lived with worrying that our meds may not be given us at any moment. If some people think complaining about this is wrong, then they shouldn’t be in HIV advocacy, but work as PR people of those failing to do their jobs.”

In the end, “this needs to be resolved fast. Enough with discussing semantics on what we’re having is a shortage or a stockout; the fact remains that there are PLHIVs not getting their supplies. Lives are at stake. So supply the ARVs; now.”

Continue Reading

POZ

HIV and AIDS Policy Act signed into law

The Philippine HIV and AIDS Policy Act updates Republic Act 8504 to incorporate lessons from the current HIV response by introducing “newer evidence-based, human rights-informed, and gender transformative strategies to prevent and treat the epidemic.”

Published

on

The Philippines now has a new law eyeing to strengthen the country’s comprehensive response against HIV and AIDS

People may already be familiar with RA 8504, or the Philippine AIDS Prevention and Control Act of 1998. When it was introduced, RA 11166 or the Philippine HIV and AIDS Policy Act intended to update Republic Act 8504 to incorporate lessons from the current HIV response by introducing “newer evidence-based, human rights-informed, and gender transformative strategies to prevent and treat the epidemic.”

The Philippine HIV and AIDS Policy Act was ratified by both the Senate and the House before Congress went on recess on October 10, 2018. It was then transmitted to Pres. Rodrigo Duterte on November 26, 2018

On December 20, 2018, Duterte signed the new law; although it was only on January 9, 2019 when it was made available to the public.

Some of the new law’s eminent features include:

  • Minors aged 15 to under 18 may now voluntarily get tested for HIV, as stated in Article IV, Section 29 (versus the need for approval of their parents or guardians, as previously required under Republic Act 8504).
  • Mandate for the Department of Health (DOH) to establish a program that would provide free and accessible anti-retroviral treatment and medication for opportunistic infections to people living with HIV who would enroll in the program.
  • Mandate for the Philippine Health Insurance Corporation to develop a benefit package for PLHIVs to include coverage for inpatient and outpatient medical and diagnostic services, including medication and treatment. It is now prohibited by law to deny PLHIVs private health and life insurance coverage and claims.
  • Development of basic and age-appropriate instruction on the causes, modes of transmission and prevention of HIV, AIDS and other sexually-transmitted infections in public and private schools, including alternative and indigenous learning systems.
  • Mandate for the Department of Education to conduct awareness-building seminars in coordination with parent-teacher organizations to provide parents and guardians with a “gender-responsive and age-sensitive HIV and AIDS education.”
  • Provision of education on HIV and AIDS shall to all public and private employers and employees, members of the military and police, overseas Filipino workers, communities and key populations at higher risk for infection.
  • Jail term of six months to two years and/or a fine of not less than ₱50,000 on anyone who discloses the information that a person has AIDS, undergone an HIV-related test, has HIV or HIV-related illnesses or has been exposed to HIV, without their written consent.
  • Prohibition of disclosure of the name, picture or any information that would identify people living with HIV and AIDS or any confidential HIV and AIDS information on media without their written consent. The mass dissemination of these confidential information would be punished with imprisonment for two years and one day to five years, and/or a fine of ₱150,000 to ₱350,000.
  • Jail term of six months to five years and/or a fine of ₱50,000 to ₱500,000 for those discriminating against PLHIVs; and may have their business permit, business license or accreditation or professional license suspended or revoked.
READ:  Canadian MSM infected with HIV despite long-term PrEP use

Incidentally, the Philippines has the fastest growing HIV epidemic in the Asia-Pacific, with infections jumping by 140% from 2010 to 2016. The country currently records 32 new HIV cases every day, though responses to this have varied – e.g. the DOH has been criticized for complaining about budget cuts, and yet spending money on a beauty pageant; while there are NGOs criticized for putting profit before service in HIV-related efforts.

Following the signing of the Philippine HIV and AIDS Act by Duterte, Secretary of Health Francisco T. Duque III released a statement via the media relations unit of the DOH stating that “the signing of the Philippine HIV and AIDS Act is a huge step forward in responding to the growing HIV epidemic in the Philippines” because now, “mabibigyan na natin ng tamang suporta ang mga Pilipinong may HIV-AIDS (we can give proper support to PLHIVs).”

But the sentiment may be put in bad light because of the ongoing ARV shortage affecting the HIV community, wth a growing number of Filipino PLHIVs now lamenting: 1. not receiving regular supplies of ARVs (some allegedly getting meds only for a week or even three days, instead of the usual three months’ supply); 2. being shifted to another ARV because their usual/regular medicines are not available due to procurement issues by the DOH; or 3. being made to use expired medicines because there are no other available medicines for them.

With the new law, the next step is now to develop and then properly execute an Implementing Rules and Regulations to guide executive officials in implementing the law, as well as the public in how to comply with the law.

READ:  Bi now, gay later?

UPDATED ON JANUARY 9: An earlier version of this article stated that the the HIV and AIDS Policy Act lapsed into law, 30 days since it was transmitted by Congress to Malacañang, where Pres. Rodrigo Duterte failed to sign it. Laws transmitted to Malacañang which are not acted on for 30 days lapse into law; and initially, it was thought that Duterte neither signed nor vetoed the HIV and AIDS Policy Act, therefore it lapsed to becomes the country’s new HIV-related law. However, the copy of the RA 11166 released by Malacañan Palace shows that the law was actually signed by the President on December 20, 2018.

Continue Reading

POZ

Community-based HIV testing effective in reaching undiagnosed populations – study

New strategies and models of HIV testing are urgently needed to reach undiagnosed populations and help them enroll in antiretroviral therapy. And here, community-based HIV screening is an effective approach.

Published

on

It is estimated that one in three people living with HIV remain undiagnosed, so that new strategies and models of HIV testing are urgently needed to reach undiagnosed populations and help them enroll in antiretroviral therapy (ART).

This was stressed by an evaluation study published in PLOS ONE, which noted that HIV testing by lay providers can serve as a critical addition to efforts to achieve the United Nations’ 90-90-90 global HIV targets by 2020 and help to cover the “last mile” of HIV services to at-risk populations.

The evaluation study was done in Vietnam by PATH, in partnership with the Vietnam Ministry of Health, the United States Agency for International Development (USAID), and the Center for Creative Initiatives in Health and Population in Hanoi. It found that community-based HIV testing is “an effective approach to reach people at risk of HIV who have never been tested or test infrequently.”

Key at-risk populations include people who inject drugs, men who have sex with men, female sex workers, and first-time HIV testers.

A cross-sectional survey of 1,230 individuals tested by lay providers found that 74% of clients belonged to at-risk populations, 67% were first-time HIV testers, and 85% preferred lay provider testing to facility-based testing. Also, lay provider testing yielded a higher HIV positivity rate compared to facility-based testing and resulted in a high ART initiation rate of 91%.

According to Dr. Kimberly Green, PATH HIV & TB director, “innovation in HIV testing is absolutely critical to meet (the 90-90-90) ambitious targets, and community-based HIV testing offers a promising solution to connect undiagnosed people with the services they need.”

READ:  Bi now, gay later?

Lay providers participating in this study belonged to community-based organizations led by at-risk populations in urban areas and to village health worker networks in rural mountainous areas. Providers used a single rapid diagnostic test in clients’ homes, at the offices of community-based organizations, or at any private place preferred by the client. This approach helped to overcome barriers that had prevented key populations from seeking facility-based testing services, such as a perceived lack of confidentiality, fear of stigma and discrimination, inconvenient service opening times and distance, and long waiting times for test results.

Clients who had an HIV-reactive test were referred to the nearest health facility for HIV confirmatory testing, and those who received a confirmed HIV-positive result were referred to a public or private clinic for enrollment in ART. Clients with non-reactive test results received counseling to re-test after three or six months and were referred to a local health facility for HIV prevention services.

The study stresses the effectiveness of HIV testing administered by non-health care workers representing key populations and frontline village health volunteers. The results also support findings from community-based HIV testing approaches in other regions, including sub-Saharan Africa, that have demonstrated comparatively high rates of HIV testing uptake, high HIV positivity yields, and high success rates in linking people to care.

Continue Reading

Editor's Picks

PSA tackles in Filipino Sign Language what happens after rapid HIV test

What happens after you get tested for HIV? Particularly to “help simplify the HIV discussion for the Deaf community in the Philippines,” a public service announcement was released on getting tested for HIV in the Philippines, and what happens after one gets tested.

Published

on

One of the biggest confusions re HIV testing in the Philippines is answering the question on “what happens after one gets tested for HIV,” said Disney Aguila, board member of Bahaghari Center for SOGIE Research, Education and Advocacy, Inc. (Bahaghari Center) and concurrent president of Pinoy Deaf Rainbow (PDR).

The confusion is not helped by numerous factors – e.g.: various testing facilities are, in a way, “autonomous”, so there are varying practices; and information about post-testing remains limited.

No matter the reason/s for the confusion, “the effect is the same: it discourages many people from getting HIV testing and/or screening,” Aguila said.

To demystify particularly rapid HIV screening to “help simplify the HIV discussion for the Deaf community in the Philippines,” a public service announcement (PSA) was released on getting tested for HIV in the Philippines, and what happens after one gets tested.

The PSA is the third in a series of PSAs produced as part of a Bahaghari Center project backed by a collaboration between Youth LEAD and Y-PEER (Asia Pacific Center), which eyed to address Sexual Reproductive Health and Rights (SRHR) needs of Young Key Populations (YKPs) in Asia and the Pacific.

PSA on HIV basics released in Filipino Sign Language

Particularly pertaining rapid HIV test, “we want to educate particularly Deaf Filipinos about post-testing – that, if you are non-reactive, there are steps you can do to stay non-reactive; and if you’re positive, help is available to help you access treatment, care and support (including getting antiretroviral medicines) so you can live a long, healthy life.”

READ:  Apple: ‘You're only fresh once. So come out while still young’

PSA on getting tested for HIV released in Filipino Sign Language

Aguila stressed that knowing one’s HIV status is important to protect oneself and others around him/her.

If one is HIV-positive, then he/she can start taking antiretroviral medicine (ARV) that will prevent the HIV (virus) from replicating and thereby help him/her stay healthy and live longer/normal lives.

And if one is HIV-negative, then he/she can take steps to stay negative (for example, by practicing safer sexual practices).

“It starts with getting oneself tested,” Aguila said, “which is why we encourage people to get tested.”

Most hospitals and clinics can give HIV testing.

Social hygiene clinics (SHC) located in select barangays can also give HIV testing and/or HIV screening.

Various non-government organizations also offer HIV testing and/or screening.

There are also people who are certified to give rapid HIV test.

A series of community-based HIV testing trainings are given to select members of the Deaf community in Metro Manila/Luzon, Visayas and Mindanao is to “empower members of the Deaf community to be more proactive in dealing with HIV by allowing the Deaf to help the Deaf.” These trainings are provided by The Red Ribbon Project, Inc.

Other supporters of the project include: Outrage Magazine, Fringe Publishing, Pinoy Deaf Rainbow, TransDeaf Philippines, Deaf Dykes United and Pinoy Deaf Queer.

Continue Reading

Editor's Picks

PSA on getting tested for HIV released in Filipino Sign Language

To demystify particularly rapid HIV testing/screening to “help simplify the HIV discussion for the Deaf community in the Philippines,” a public service announcement (PSA) was released on the getting tested for HIV in the Philippines.

Published

on

Getting tested for HIV is – as it is – already challenging for Hearing people, but “it can be argued that this is doubly difficult for Deaf people,” said Disney Aguila, board member of Bahaghari Center for SOGIE Research, Education and Advocacy, Inc. (Bahaghari Center) and concurrent president of Pinoy Deaf Rainbow (PDR). This is because “aside from dealing with the ‘usual’ issues related to getting tested for HIV that are encountered by Hearing people (including dealing with stigma and discrimination), we also have to contend with language barrier.”

Eyeing to demystify particularly rapid HIV testing/screening to “help simplify the HIV discussion for the Deaf community in the Philippines,” a public service announcement (PSA) was released on the getting tested for HIV in the Philippines.

The PSA is actually one in three PSAs produced as part of a Bahaghari Center project backed by a collaboration between Youth LEAD and Y-PEER (Asia Pacific Center), which eyed to address Sexual Reproductive Health and Rights (SRHR) needs of Young Key Populations (YKPs) in Asia and the Pacific.

PSA on HIV basics released in Filipino Sign Language

Particularly pertaining rapid HIV test, “we want to educate people that all it takes is a prick, and a person can already find out his/her HIV status… in less than 20 minutes,” Aguila said.

Knowing one’s HIV status is important, Aguila added, as a means to: protect oneself and others around him/her.

If one is HIV-positive, then he/she can start taking antiretroviral medicine (ARV) that will prevent the HIV (virus) from replicating and thereby help him/her stay healthy and live longer/normal lives.

READ:  On starting antiretroviral therapy early

And if one is HIV-negative, then he/she can take steps to stay negative (for example, by practicing safer sexual practices).

“But it all starts with getting oneself tested,” Aguila said, “which is why we encourage people to get tested.”

If these are more accessible, most hospitals and clinics can give HIV testing.

Social hygiene clinics (SHC) located in select barangays can also give HIV testing and/or HIV screening.

Various non-government organizations also offer HIV testing and/or screening.

There are also people who are certified to give rapid HIV test.

A series of community-based HIV testing trainings are given to select members of the Deaf community in Metro Manila/Luzon, Visayas and Mindanao is to “empower members of the Deaf community to be more proactive in dealing with HIV by allowing the Deaf to help the Deaf.” These trainings are provided by The Red Ribbon Project, Inc.

Other supporters of the project include: Outrage Magazine, Fringe Publishing, Pinoy Deaf Rainbow, TransDeaf Philippines, Deaf Dykes United and Pinoy Deaf Queer.

Continue Reading
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

Facebook

Most Popular